Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aidapak Services, LLC is recalling 2,799 Omega-3 Fatty Acid capsules because they may be mislabeled as Docusate Calcium. The error could lead to patients receiving the wrong medication.
Mariposa Labs is recalling NorthStar Arthritis Relief Cream because the product failed microbiological specifications.
Aidapak Services is recalling methylprednisolone tablets that may be mislabeled as levothyroxine sodium due to a labeling mixup.
Aidapak Services, LLC is recalling Pramipexole Di-HCl tablets that may be mislabeled as Liothyronine Sodium. The error poses a risk of incorrect medication administration.
Lupin Pharmaceuticals is recalling Quinapril 10 mg tablets because stability testing revealed an unknown impurity above specification limits.
Aidapak Services is recalling 1,582 Nicotine Polacrilex Lozenges because they may be mislabeled as other prescription drugs.
Aidapak Services is recalling 700-tablet bottles of 20 mg Famotidine tablets because they may be mislabeled as other medications.
Aidapak Services is recalling Leflunomide 10 mg tablets because they may be mislabeled as Doxycycline or Sevelamer Carbonate.
Aidapak Services is recalling Aripiprazole 2 mg tablets because they may be mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling guaiFENesin ER tablets because they may be mislabeled as fenofibrate or glyburide. The error poses a risk of patients taking the wrong medication.
Aidapak Services, LLC is recalling Mirtazapine 7.5 mg tablets because they may be mislabeled as other prescription medications.
Aidapak Services is recalling lamoTRIgine tablets that may be mislabeled as oxybutynin chloride or fexofenadine HCL. The error could lead to patients taking the wrong medication.
Specialty Medicine Compounding Pharmacy is recalling repackaged Bevacizumab because sterility cannot be assured. The recall affects 2,801 doses distributed in Michigan.
Aidapak Services, LLC is recalling Isosorbide Mononitrate ER tablets because they may be mislabeled as other prescription drugs.
Watson Laboratories is recalling 4,439 bottles of Carisoprodol Tablets because metal particulates were visually observed in the tablets.
The Compounding Center at Blue Ridge is recalling PGE 20 mcg/mL and 40 mcg/mL injectables due to quality control concerns regarding sterility assurance identified during an FDA inspection.
The Compounding Center at Blue Ridge is recalling all lots of Papaverine/Phentolamine injections due to quality control concerns regarding sterility assurance identified during an FDA inspection.
The Compounding Center at Blue Ridge is recalling 92 units of Triple Mix Injectable due to quality control concerns identified during an FDA inspection.
The FDA is recalling all lots of Super Triple Mix Injectable from The Compounding Center at Blue Ridge due to quality control concerns regarding sterility assurance.
The Compounding Center at Blue Ridge is recalling all lots of Quad Mix Injectable due to quality control concerns identified during an FDA inspection.
Hospira Inc. is recalling 65,109 vials of Bupivacaine Hydrochloride with Epinephrine due to a potential breach in the aseptic process caused by equipment failure.
Teva Pharmaceuticals USA is recalling specific lots of Daunorubicin Hydrochloride Injection because the drug product contains precipitate.
GlaxoSmithKline is recalling 9,743 cartridges of Sumatriptan Succinate Injection because some may have needles protruding through the shield, compromising sterility.
Physicians Total Care is recalling Carisoprodol 350mg tablets because heavy metals and inactive components were found during routine stability testing.
GlaxoSmithKline is recalling 10,469 Imitrex STATdose Systems because some syringes may have needles protruding through the shield, compromising sterility.